Centro De Hematologia & Oncologia Medica Ashford is categorized under Doctors in , .
Centro De Hematologia & Oncologia Medica Ashford was established in 0, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Dra Hilda E R Quiones at the company’s single location by writing to 29 Ashford Avenue Washinton # 604 Washington, , 00907 or by phoning (787) 725-6356. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Centro De Hematologia & Oncologia Medica Ashford |
| Contact Person: | Dra Hilda E R Quiones |
| Address: | 29 Ashford Avenue Washinton # 604 Washington, , 00907 |
| Phone Number: | (787) 725-6356 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Centro De Hematologia & Oncologia Medica Ashford was started in 0 to provide professional Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Dra Hilda E R Quiones for inquiries that concern Centro De Hematologia & Oncologia Medica Ashford by calling the company number (787) 725-6356, as your correspondence is most welcome. Additionally, the physical location of the single location of Centro De Hematologia & Oncologia Medica Ashford can be found at the coordinates as well as the street address 29 Ashford Avenue Washinton # 604 Washington in , 00907.
For its online presence, you may visit Centro De Hematologia & Oncologia Medica Ashford’s website at and engage with its social media outlets through on Twitter and on Facebook.